Clinical Trial Update: A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BL-B01D1, SI-B003, and their combination in patients with recurrent or metastatic head and neck squamous cell carcinoma and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• BL-B01D1
• BL-B01D1 + SI-B003
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING